No relevant relationships with ineligible companies to disclose within the past 24 months.
This presentation covers non-opioid medication management options to help provide patients a reduction in chronic pain and improve functionality and quality of life. Medication categories such as prostaglandin inhibitors, membrane stabilizers, norepinephrine reuptake inhibitors, central nervous system depressants, and others will be discussed.
Learning Objectives:
At the conclusion of this session, participants should be able to:
Define nociceptive, neuropathic, and nociplastic pain
Discuss opioid induced hyperalgesia
Develop a treatment plan utilizing antidepressants, membrane stabilizers, prostaglandin inhibitors, topical analgesics, CNS depressants, NMDA antagonists, and opioid antagonists
